China Resources Double-Crane Pharmaceutical Co., Ltd. at its special shareholders' meeting of 2014 on June 25, 2014, which discussed and approved the proposal of Zhang Wenzhou's resignation from the position of Independent Director and the proposal of recommendation of Wu Zhi'ang Independent Director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.69 CNY | +0.23% | -4.20% | +16.61% |
10:08am | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
05-23 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Market Schizophrenia Drug | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.61% | 3.06B | |
+38.51% | 727B | |
+32.42% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.22% | 205B | |
-5.64% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 600062 Stock
- News China Resources Double-Crane Pharmaceutical Co.,Ltd.
- China Resources Double-Crane Pharmaceutical Co., Ltd. Announces Board Changes